The HPI

The institute's mission statement: „The HPI investigates the biology of human pathogenic viruses. It is our aim to unravel the molecular mechanisms that control viral life cycles and virus induced pathogenesis. This research will provide novel targets and therapeutic approaches for established and emerging viral disease.Learn more about the HPI.

Research Units

The Heinrich Pette Institute's research teams currently consist of four reserach units, three reserach groups and three independent junior research groups.

For more information visit the RESEARCH Teams.

European Congress of Virology

Oktober 19-22, 2016 at the Congress Center Hamburg

More Infos HERE

Leibniz Year 2016

Leibniz Year 2016 -  the 370. birthday and 300. anniversary of death of the polymath Gottfried Wilhelm Leibniz: Reason for a Theme Year by the Leibniz Association.

www.bestewelten.de

News

February 3, 2016: School Visit at the HPI

Wednesday, 03. February 2016

February 3, 2016: Pupils got insights into the work areas of the institute

January 28, 2016: Farewell celebration for Dr. Carol Stocking

Thursday, 28. January 2016

January 28, 2016: Dr. Carol Stocking retires

Press

European Alliance dedicated to accelerating new concepts in HIV Vaccine research

Wednesday, 27. January 2016

Heinrich Pette Institute, Leibniz Institute for Experimental Virology receives 965,000 Euros from the European Union's Horizon 2020 Research and Innovation Programme

Vaccines- International symposium & public panel discussion in Hamburg

Wednesday, 20. January 2016

Symposium and panel discussion presented by the Leibniz Center Infection (LCI) focus on "Vaccines“

Seminars

The Impact of Genetic Variation on HIV Disease

Thursday, 18. February 2016 - 15:15

Prof. Mary Carrington

Fredrick National Laboratory for Cancer Research, National Cancer Institute, Frederick, USA

im Ferdinand-Bergen-Auditorium des HPI

New insights into the role of p300, BRD4 and AP1 for papillomavirus-induced tumor formation in a rabbit animal model system

Thursday, 25. February 2016 - 15:15

Prof. Thomas Iftner

Sektion Experimentelle Virologie, Institut für Virologie, Universitätsklinikum Tübingen

im Ferdinand-Bergen-Auditorium des HPI